CRISPR/Cas9 endonuclease-mediated genome editing is used to insert a 9 amino acid (YPYDVPDYA) hemagluttin (HA) tag in N-terminus. In addition, the insertion included three silent point mutation located in the PAM site to eliminate recleavage. (J:292643)
Legend:
cx: complex: > 1 genome feature ot: other: hemizygous, indeterminate,... (F): Female
(M): Male
N: normal phenotype
(#): related diseases count